New report published by Global Info Research which offers insights on the global IGY Polyclonal Antibodies market.
Immunoglobulin Y (abbreviated as IgY) is a type of immunoglobulin which is the major antibody in bird, reptile, and lungfish blood. It is also found in high concentrations in chicken egg yolk. As with the other immunoglobulins, IgY is a class of proteins which are formed by the immune system in reaction to certain foreign substances, and specifically recognize them.
IgY antibodies have a different structure from IgG, particularly in the Fc and hinge regions. The affinity maturation process of IgY is also different from IgG. These biological features underlie IgY’s competitive advantages over IgG. Shown in the four panels are several comparisons between IgY and IgG.
Click to view the full report TOC, figure and tables:
Global IGY Polyclonal Antibodies Market: Forecast by Type / Application / Region
IgY is a hen egg polyclonal antibody. Hen eggs contain more than 450 separate antibodies and when consumed, are not rejected by the human immune system.
The scientific community has long known that IgY has the proven ability to modulate immune systems. The G.I. tract is the typical entry point for foreign pathogens. By removing pathogens IgY can alleviate stress on the overall system thereby optimizing the body’s natural defense systems. When consumed orally or topically, IgY can identify and attack foreign pathogens that enter via the gut. Antibodies work on both viral and bacterial infections possibly reducing the need for antibiotics.
The major players in global market include: Merck, IGY Life Sciences, Abcam, Genway Biotech, Good Biotech, Gallus Immunotech, Creative Diagnostics, Agrisera, Innovagen AB, Capra Science, YO Proteins, GeneTex.
On the basis of product, the IGY Polyclonal Antibodies market is primarily split into: Primary Antibody, Secondary Antibody.
On the basis on the end users/Applications covers: Academic Research, Commercial.
In the last several years, global market of IGY Polyclonal Antibodies developed rapidly, with an average growth rate of 14.05%. In 2017, global revenue of IGY Polyclonal Antibodies is about 4.32 million USD.
The classification of IGY Polyclonal Antibodies includes Primary Antibody and Secondary Antibody. The proportion of Primary Antibody in 2017 is about 70%, and the proportion of Secondary Antibody in 2017 is about 30%.
IGY Polyclonal Antibodies are application in Academic Research and Commercial. The most of IGY Polyclonal Antibodies is used in Commercial, and the market share of that is about 60 % in 2017.
North America is the largest consumption place, with a consumption market share nearly 37.5% in 2017; Europe is the second largest consumption place with the consumption market share of 30% in 2017.
Market competition is not intense. Merck, IGY Life Sciences, Abcam, Genway Biotech, Good Biotech etc. are the leaders of the industry with the market share are about 66% in 2017.
Ask for Discount on Research Report and Request Sample Copy of Report@
GlobalInfoResearch is a report publisher, a customer, interest-based suppliers. Is in the best interests of our clients, they determine our every move. At the same time, we have great respect for the views of customers. With the improvement of the quality of our research, we develop custom interdisciplinary and comprehensive solution. For further development, we will do better and better. GlobalInfoResearch will with excellent professional knowledge and experience to carry out all aspects of our business. At the same time, we will thoroughly look for information, to give a more comprehensive development.
United States IGY Polyclonal Antibodies Market 2018 Forecast to 2023
Europe IGY Polyclonal Antibodies Market 2018 Forecast to 2023
North America IGY Polyclonal Antibodies Market 2018 Forecast to 2023
Asia-Pacific IGY Polyclonal Antibodies Market 2018 Forecast to 2023
China IGY Polyclonal Antibodies Market 2018 Forecast to 2023
EMEA IGY Polyclonal Antibodies Market 2018 Forecast to 2023
Global IGY Polyclonal Antibodies Market 2018 Forecast to 2023
Contact US :
Sales Director (Global Info Research)
Tel: +86-13660489451 00852-58197708(HK)
Add: RM 1605C HO KING COMM CTR 2-16 FA YUEN ST MONGKOK KL Hong Kong